Decrease of skin infiltrating and circulating CCR10+ T cells coincides with clinical improvement after topical tacrolimus in Omenn syndrome.
Faaij
Claudia M
CM
Annels
Nicola E
NE
Ruigrok
Geertje
G
van der Burg
Mirjam
M
Ball
Lynne M
LM
Bredius
Robbert G
RG
van Tol
Maarten J
MJ
Lankester
Arjan C
AC
D000287:Administration, Topical; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D054447:Receptors, CCR10 / Q000378:metabolism; D016511:Severe Combined Immunodeficiency / Q000188:drug therapy* / Q000276:immunology*; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D016559:Tacrolimus / Q000494:pharmacology*; D016896:Treatment Outcome
C515706:CCR10 protein, human; D007166:Immunosuppressive Agents; D054447:Receptors, CCR10; D016559:Tacrolimus